These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz). Bazika V Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450 [TBL] [Abstract][Full Text] [Related]
9. [Improvement of the functional capacity of hypertensive patients treated with guanfacine]. Bazika V; Neuzil P; Tiserová J; Hrabovský F Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943 [No Abstract] [Full Text] [Related]
10. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome. Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275 [TBL] [Abstract][Full Text] [Related]
11. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)]. Rosenthal J; Jäger H MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938 [TBL] [Abstract][Full Text] [Related]
12. [Anti-hypertensive effectiveness of guanfacine and methyldopa: comparison of groups of patients]. Malini PL; Strocchi E; Ambrosioni E; Magnani B Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765262 [No Abstract] [Full Text] [Related]
13. Long-term efficacy and tolerance of the antihypertensive agent guanfacine. Jerie P; Lasance A Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876 [TBL] [Abstract][Full Text] [Related]
14. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
15. [Anti-hypertensive efficacy of guanfacine and methyldopa: intra-patient comparison]. Malini PL; Strocchi E; Ambrosioni E; Magnani B Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765437 [No Abstract] [Full Text] [Related]
16. [The place of guanfacine in the treatment of essential arterial hypertension]. Koaté P; Diouf S; Sylla M; Sarr M; Ba SA Dakar Med; 1983; 28(2):321-36. PubMed ID: 6360603 [No Abstract] [Full Text] [Related]
17. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance]. Schäfer N; Knaup G Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756 [No Abstract] [Full Text] [Related]
18. [Efficacy of guanfacine in the treatment of arterial hypertension]. de Broucker D; Graux P; Dutoit A; Croccel L LARC Med; 1982; 2(7):613-5. PubMed ID: 6762476 [No Abstract] [Full Text] [Related]
19. [A clinical study of guanfacine in the treatment of arterial hypertension]. Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951 [No Abstract] [Full Text] [Related]
20. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]